Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Surgical Procedures, Operative × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 5 CNS 5 Gastrointestinal 4 Head & Neck 2 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Urinary Bladder Neoplasms 11 Prostatic Neoplasms 10 Kidney Neoplasms 6 Wilms Tumor 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma, Renal Cell 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Testicular Neoplasms 1 Teratoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Prostate CA 1 Prostate Adenocarcinoma 1 Pain, Postoperative 1 Pain 1 Ovarian Germ Cell Cancer 1 Oligometastatic Renal Cell Carcinoma 1 Neoplasms, Second Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer 1 Lung Neoplasms 1 Endodermal Sinus Tumor 1 Directly Observed Therapy 1 Carcinoma, Transitional Cell 1 Adenocarcinoma 1 Acute Kidney Injury 1

Interventions

pembrolizumab 21 Docetaxel 19 Gemcitabine 13 Paclitaxel 12 Nivolumab 11 pazopanib 10 Radiotherapy 9 Prednisone 9 Sorafenib 8 Therapeutics 7 Leuprolide 7 Ipilimumab 7 Cyclophosphamide 7 Carboplatin 7 Bevacizumab 7 avelumab 6 Thalidomide 6 Sunitinib 6 Cetuximab 6 Blood Specimen Collection 6 Axitinib 6 atezolizumab 5 Standard of Care 5 Radiosurgery 5 Radiation 5 Interleukin-2 5 Denosumab 5 temsirolimus 4 bicalutamide 4 Psychiatric Rehabilitation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00491621 2015-06-04

CMM

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Kidney Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡